Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03776461 · ClinicalTrials.gov registry record · NA

Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles

A NA study, sponsored by Venus Concept.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT03776461 is a NA study that has completed, run by Venus Concept. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03776461, a NA study, has completed, sponsored by Venus Concept.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of facial wrinkles.

Interventions

  • DEVICE Venus Viva

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2019-03-08
Est. Completion 2021-06-18
Phase NA

Sponsor

Venus Concept

22 total trials

What the Registry Record Tells You About NCT03776461

The ClinicalTrials.gov registry entry for NCT03776461 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Venus Viva is the first listed.

NCT03776461 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03776461 about?

NCT03776461 is a clinical study titled "Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles". Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of facial wrinkles.

What is the current status of trial NCT03776461?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-03-08. Estimated completion is 2021-06-18.

What interventions are being tested in trial NCT03776461?

The interventions under investigation include: Venus Viva (DEVICE).

Who is sponsoring clinical trial NCT03776461?

This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.